Exenatide (Byetta) – A GLP-1 Agonist for Type 2 Diabetes Management

 Exenatide (Byetta) is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes. It mimics natural GLP-1, a hormone that regulates blood sugar levels and appetite.

Mechanism of Action

Exenatide works by stimulating insulin secretion, slowing gastric emptying, and reducing glucagon release. These combined effects help lower blood glucose levels after meals.

Key Benefits

• Improves Blood Sugar Control – Lowers A1C levels and post-meal glucose spikes.
• Aids in Weight Loss – Reduces appetite, leading to decreased calorie intake.
• Cardiovascular Benefits – May reduce heart disease risk factors.

Potential Side Effects

Some patients experience nausea, vomiting, diarrhea, or injection site reactions. Rare cases of pancreatitis have been reported.

Exenatide remains a widely used and effective treatment for type 2 diabetes, particularly for those needing weight management support.